Table II.
Association of ARPC2 expression with clinicopathological parameters from breast cancer patients.
| ARPC2 expression | ||||
|---|---|---|---|---|
| Parameter | n | High | Low or none | P-value |
| Age (years) | ||||
| ≤35 | 6 | 4 | 2 | 0.075 |
| 36–55 | 111 | 57 | 54 | |
| >60 | 55 | 28 | 27 | |
| Tumor size (cm) | ||||
| ≤2 | 41 | 16 | 25 | <0.05 |
| 3–5 | 110 | 51 | 59 | |
| >6 | 21 | 15 | 6 | |
| Lymph node involvement | ||||
| pN0 | 79 | 35 | 44 | <0.05 |
| pN1 | 45 | 24 | 21 | |
| pN2 | 48 | 35 | 13 | |
| Grade | ||||
| I | 79 | 38 | 41 | <0.05 |
| II | 45 | 25 | 20 | |
| III | 48 | 32 | 16 | |
| Stage | ||||
| I | 24 | 9 | 15 | 0.65 |
| II | 132 | 66 | 66 | |
| III–IV | 16 | 7 | 9 | |
| ER | ||||
| + | 106 | 37 | 69 | 0.864 |
| − | 66 | 24 | 42 | |
| PR | ||||
| + | 96 | 46 | 50 | 0.65 |
| − | 76 | 37 | 40 | |
| HER-2 | ||||
| + | 47 | 25 | 22 | 0.288 |
| − | 125 | 70 | 55 | |
ARPC2, actin-related protein 2/3 complex; ER, estrogen receptor; PR, progesterone receptor.